Joel Greenblatt Bio Techne Corp Transaction History

Gotham Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $892,452 - $3.9 Million	11,063 Added 307.13%	14,665 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $269,825 - $374,216	955 Added 36.08%	3,602 $1.02 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $123,259 - $171,766	-382 Reduced 12.61%	2,647 $918,000
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $1.07 Million - $1.48 Million	3,029 New	3,029 $1.31 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $490,817 - $564,964	-1,076 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $478,680 - $579,834	1,076 New	1,076 $521,000
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $218,436 - $257,896	-1,190 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $224,576 - $256,361	1,190 New	1,190 $248,000
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $3.19 Million - $3.54 Million	-26,305 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $2.99 Million - $3.26 Million	26,305	26,305 $3.18 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.